101 related articles for article (PubMed ID: 7965755)
1. Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.
Thummel KE; Shen DD; Podoll TD; Kunze KL; Trager WF; Hartwell PS; Raisys VA; Marsh CL; McVicar JP; Barr DM
J Pharmacol Exp Ther; 1994 Oct; 271(1):549-56. PubMed ID: 7965755
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 1Beta- and 5Beta-hydroxylation of Deoxycholate and Glycodeoxycholate as In Vitro Index Reactions for Cytochrome P450 3A Activities.
Wang C; Cheng B; Wei W; Gui L; Zeng W; Wang Y; Wang Y; Chen Q; Xu L; Miao J; Lan K
Drug Metab Dispos; 2024 Jan; 52(2):126-134. PubMed ID: 38050044
[TBL] [Abstract][Full Text] [Related]
3. Danazol increases the oral bioavailability of midazolam by inactivation of hepatic and intestinal CYP3A in rats.
Fukuno S; Nagai K; Kurotobi A; Sahori Y; Nakagawa R; Nomura R; Ito T; Konishi H
Xenobiotica; 2023 May; 53(5):421-428. PubMed ID: 37640546
[TBL] [Abstract][Full Text] [Related]
4. Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.
Denisov IG; Grinkova YV; McLean MA; Camp T; Sligar SG
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740978
[TBL] [Abstract][Full Text] [Related]
5. Differences of Atomic-Level Interactions between Midazolam and Two CYP Isoforms 3A4 and 3A5.
Liu S; Zheng Q; Bai F
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836743
[TBL] [Abstract][Full Text] [Related]
6. Introducing the Dynamic Well-Stirred Model for Predicting Hepatic Clearance and Extraction Ratio.
Yan Z; Ma L; Carione P; Huang J; Hwang N; Kenny JR; Hop CECA
J Pharm Sci; 2024 Apr; 113(4):1094-1112. PubMed ID: 38220087
[TBL] [Abstract][Full Text] [Related]
7. Quantitative prediction of CYP3A-mediated drug-drug interactions by correctly estimating fraction metabolized using human liver chimeric mice.
Miyake T; Mochizuki T; Nakagawa T; Nakamura M; Emoto C; Komiyama N; Hirabayashi M; Tsuruta S; Shimojo T; Terao K; Tachibana T
Br J Pharmacol; 2024 Apr; 181(7):1091-1106. PubMed ID: 37872109
[TBL] [Abstract][Full Text] [Related]
8. Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.
Thummel KE; Shen DD; Podoll TD; Kunze KL; Trager WF; Bacchi CE; Marsh CL; McVicar JP; Barr DM; Perkins JD
J Pharmacol Exp Ther; 1994 Oct; 271(1):557-66. PubMed ID: 7965756
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
10. The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review.
van der Heijden LT; Opdam FL; Beijnen JH; Huitema ADR
Eur J Drug Metab Pharmacokinet; 2024 Apr; ():. PubMed ID: 38689161
[TBL] [Abstract][Full Text] [Related]
11. Towards More Robust Evaluation of the Predictive Performance of Physiologically Based Pharmacokinetic Models: Using Confidence Intervals to Support Use of Model-Informed Dosing in Clinical Care.
van Borselen MD; Sluijterman LAÆ; Greupink R; de Wildt SN
Clin Pharmacokinet; 2024 Mar; 63(3):343-355. PubMed ID: 38361163
[TBL] [Abstract][Full Text] [Related]
12. Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine.
Jackson KD; Achour B; Lee J; Geffert RM; Beers JL; Latham BD
Drug Metab Dispos; 2023 Oct; 51(10):1238-1253. PubMed ID: 37419681
[TBL] [Abstract][Full Text] [Related]
13. What Is Known about Midazolam? A Bibliometric Approach of the Literature.
Corôa MCP; Mendes PFS; Baia-da-Silva DC; Souza-Monteiro D; Ferreira MKM; Braga GLC; Damasceno TV; Perdigão JM; Lima RR
Healthcare (Basel); 2022 Dec; 11(1):. PubMed ID: 36611556
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion.
Nassar YM; Hohmann N; Michelet R; Gottwalt K; Meid AD; Burhenne J; Huisinga W; Haefeli WE; Mikus G; Kloft C
Clin Pharmacokinet; 2022 Nov; 61(11):1595-1607. PubMed ID: 36195807
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and cardiovascular status impact midazolam pharmacokinetics in critically ill children: An observational, prospective, controlled study.
Neupane B; Pandya H; Pandya T; Austin R; Spooner N; Rudge J; Mulla H
Pharmacol Res Perspect; 2022 Oct; 10(5):e01004. PubMed ID: 36036654
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and pharmacodynamics of midazolam after intravenous administration to donkeys
O O; Simon BT; Ebner LS; Lizarraga I; Sun X; Cox SK
Can J Vet Res; 2022 Apr; 86(2):125-131. PubMed ID: 35388227
[TBL] [Abstract][Full Text] [Related]
17. Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males.
Toyama K; Furuie H; Kuroda K; Ishizuka T; Okuda Y; Shimizu T; Kato M; Igawa Y; Nishikawa Y; Ishizuka H
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):685-694. PubMed ID: 34383278
[TBL] [Abstract][Full Text] [Related]
18. Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans.
Matthaei J; Bonat WH; Kerb R; Tzvetkov MV; Strube J; Brunke S; Sachse-Seeboth C; Sehrt D; Hofmann U; von Bornemann Hjelmborg J; Schwab M; Brockmöller J
Front Genet; 2020; 11():944. PubMed ID: 32973880
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology Patients.
van de Velde ME; Panetta JC; Wilhelm AJ; van den Berg MH; van der Sluis IM; van den Bos C; Abbink FCH; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Evans WE; Kaspers GL
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32635465
[TBL] [Abstract][Full Text] [Related]
20. Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate.
van Dyk M; Kapetas AJ; Hopkins AM; Rodrigues AD; Vourvahis M; Sorich MJ; Rowland A
Front Pharmacol; 2019; 10():1120. PubMed ID: 31611799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
